Evidence map›Paper›PMID 40341584›Full record

ArticleBioelectromagnetics2025

5G EMF Exposure at 3.6 GHz in Greece Using Data From Frequency-Selective Monitoring Sensors.

Serafeim Iakovidis, Athanasios Manassas, Christos Apostolidis, Theodoros Samaras

Abstract read
In one paragraph

Article in Bioelectromagnetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Serafeim IakovidisCIRI-Center for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki, Thermi, Greece.ORCID http://orcid.org/0000-0002-1090-8755
Athanasios ManassasCIRI-Center for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki, Thermi, Greece.
Christos ApostolidisCIRI-Center for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki, Thermi, Greece.
Theodoros SamarasCIRI-Center for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki, Thermi, Greece.ORCID http://orcid.org/0000-0003-0170-4520

Funding

Funding for this study was provided by the European Union's Horizon Europe Framework Programme under Grant Agreement number 101057622 (SEAWave Project).
6 · The paper itself

Abstract

The introduction of 5G networks has raised public concerns about potential changes in environmental electromagnetic field (EMF) exposure. This study analyzes continuous monitoring data collected over 2 years (August 2022-October 2024) from 13 frequency-selective monitoring sensors located in Greece's five largest cities. Focusing on the 3.6 GHz band, we evaluated trends and weekly variations in EMF levels. Results indicated a gradual increase in EMF exposure at 3.6 GHz, driven by the growing penetration of 5G infrastructure and devices. Notably, this band exhibited higher maximum-to-median power density ratios compared to other frequency bands, attributable to active antenna systems' characteristics and traffic variations. Applying the ICNIRP 2020 guidelines, we found that 30-min averaged values significantly reduced these variations. All measured EMF levels, including maximum values, remained well below Greek and international safety limits. These findings, especially the increasing trend identified for the EMF levels, underscore the importance of continuous monitoring networks for assessing EMF exposure to existing and emerging telecommunications networks and ensuring compliance with safety standards.

Indexed as

Electromagnetic FieldsEnvironmental ExposureRadiation ExposureRadiation MonitoringGreeceHumans

Identifiers

PMID40341584
PMCPMC12060845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.